350 Capital
15.1K posts

350 Capital
@captainkingjon
I need my $1-$2 stocks to hit $3.50, so that I can payoff that gosh darn Lockness Monster!



$HIMS Everyone knows Ozempic now. It peaked mid-2024 and became a household name. You can ask almost anyone and they’ll know what it is or at least what it does. Now look at “peptides.” Most people you know have no idea what that even means. Ask someone close to you. They won’t have a clue. But search interest is telling you something very different. It’s accelerating fast and is now approaching where Ozempic was at peak attention. Peptides are short chains of amino acids that influence specific biological pathways. They can target fat loss, muscle growth, recovery, inflammation, and longevity. The scope is broad and still evolving. It is early, fragmented, and not yet understood by the public. Which is exactly why the opportunity exists. That’s where HIMS comes in. They’ve already proven they can take a stigmatized or complex category and make it simple, accessible, and consumer-friendly at scale. They did it with hair loss. They did it with ED. They are doing it with weight loss. When peptides move from niche/black market to mainstream, HIMS is one of the few platforms positioned to capture that demand early and package it for the mass market. You don’t need to guess if people are interested. Search is already telling you. Ozempic is already a household name. Peptides are next.




$PSKY "Paramount" Bullflag forming after our monster 32% Run from bottom. Key important point is waiting the breakout with volume here. Last week Paramount secured 24B $ in equity commitment from middle east to secure the WarnerBros deal




RFK Jr. said the FDA plans to remove 12 peptides from Category 2. Moving peptides out of the gray market and into regulated channels could create a more credible and scalable opportunity for $HIMS.


@Ren_aramb Yeah, I can see $SIVE easily 10xing from current levels.











